Tandem Diabetes Care Inc (FRA:TD5A)
€ 46.5 -0.61 (-1.29%) Market Cap: 3.09 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 13.74 GF Score: 77/100

Tandem Diabetes Care Inc at Jefferies London Healthcare Conference Transcript

Nov 14, 2023 / 08:30AM GMT
Release Date Price: €14 (+2.49%)
Matthew Charles Taylor
Jefferies LLC, Research Division - Equity Analyst

I'm Matt Taylor, the U.S. medical supplies and devices analyst. I'm pleased to be joined by management from Tandem Diabetes Care. So we have John Sheridan, the CEO; and Leigh Vosseller, the CFO. And this is meant to be a fireside chat. I think if anybody has burning questions, it's okay, if you want to raise your hand a little bit through the session here.

But John, maybe to start, there are some folks here that probably don't know the story in the weeds at a deep level. Maybe you could just give us a little bit of an overview on where Tandem sits in the insulin pump market, talk a little bit about your legacy technology innovations and a sense for sort of where we are in the river. You have a lot of new technologies to come out over the next 6 months and maybe one of the most...

John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director

Six weeks.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot